Therapeutic Insights from Genomic Studies of Head and Neck Squamous Cell Carcinomas

Overview

Journal Cancer Discov

Specialty Oncology

Date 2015 Feb 4

PMID 25643909

Citations 62

Authors

Peter S Hammerman

D Neil Hayes

Jennifer R Grandis

Affiliations

Soon will be listed here.

Abstract

Large and comprehensive genomic surveys of head and neck squamous cell carcinomas (HNSCC) are now greatly increasing our understanding of the diversity of this disease and the key genomic changes that drive these tumors. The results from these studies are beginning to inform the introduction of novel therapies for patients with HNSCCs. Here, we review some of the key findings from recent genomic studies of head and neck cancers, including the most comprehensive study to date from The Cancer Genome Atlas Network.

Citing Articles

PINCH-1 promotes tumor growth and metastasis by enhancing DRP1-mediated mitochondrial fission in head and neck squamous cell carcinoma.

Tian R, Song H, Li J, Yuan T, Liu J, Wang Y Cancer Biol Ther. 2025; 26(1):2477365.

PMID: 40065703 PMC: 11901378. DOI: 10.1080/15384047.2025.2477365.

Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck.

Luo J, Bishop J, Dubois S, Hanna G, Sholl L, Stelow E Nat Rev Clin Oncol. 2025; .

PMID: 39900969 DOI: 10.1038/s41571-025-00986-3.

TRIM47 promotes head and neck squamous cell carcinoma malignant progression by degrading XAF1 through ubiquitination.

Yu C, Zhang C, Zhang Q, Zhang C, Han J, Li J iScience. 2025; 28(1):111590.

PMID: 39834862 PMC: 11743097. DOI: 10.1016/j.isci.2024.111590.

Structural insights into the role and targeting of EGFRvIII.

Bagchi A, Stayrook S, Xenaki K, Starbird C, Doulkeridou S, El Khoulati R Structure. 2024; 32(9):1367-1380.e6.

PMID: 38908376 PMC: 11380598. DOI: 10.1016/j.str.2024.05.018.

Construction of a prognosis model of head and neck squamous cell carcinoma pyroptosis and an analysis of immuno-phenotyping based on bioinformatics.

Pan W, Huang W, Zheng J, Meng Z, Pan X Transl Cancer Res. 2024; 13(1):299-316.

PMID: 38410218 PMC: 10894328. DOI: 10.21037/tcr-23-922.

References

Walter V, Yin X, Wilkerson M, Cabanski C, Zhao N, Du Y . Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes. PLoS One. 2013; 8(2):e56823. PMC: 3579892. DOI: 10.1371/journal.pone.0056823. View

Stransky N, Egloff A, Tward A, Kostic A, Cibulskis K, Sivachenko A . The mutational landscape of head and neck squamous cell carcinoma. Science. 2011; 333(6046):1157-60. PMC: 3415217. DOI: 10.1126/science.1208130. View

Agrawal N, Frederick M, Pickering C, Bettegowda C, Chang K, Li R . Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011; 333(6046):1154-7. PMC: 3162986. DOI: 10.1126/science.1206923. View

Chaturvedi A, Engels E, Pfeiffer R, Hernandez B, Xiao W, Kim E . Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29(32):4294-301. PMC: 3221528. DOI: 10.1200/JCO.2011.36.4596. View

Chung C, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N . Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol. 2006; 24(25):4170-6. DOI: 10.1200/JCO.2006.07.2587. View

Lui V, Hedberg M, Li H, Vangara B, Pendleton K, Zeng Y . Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov. 2013; 3(7):761-9. PMC: 3710532. DOI: 10.1158/2159-8290.CD-13-0103. View

Ang K, Harris J, Wheeler R, Weber R, Rosenthal D, Nguyen-Tan P . Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010; 363(1):24-35. PMC: 2943767. DOI: 10.1056/NEJMoa0912217. View

Smeets S, Braakhuis B, Abbas S, Snijders P, Ylstra B, van de Wiel M . Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene. 2005; 25(17):2558-64. DOI: 10.1038/sj.onc.1209275. View

Edge S, Compton C . The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17(6):1471-4. DOI: 10.1245/s10434-010-0985-4. View

10.

Ojesina A, Lichtenstein L, Freeman S, Pedamallu C, Imaz-Rosshandler I, Pugh T . Landscape of genomic alterations in cervical carcinomas. Nature. 2014; 506(7488):371-5. PMC: 4161954. DOI: 10.1038/nature12881. View

11.

Pickering C, Zhang J, Neskey D, Zhao M, Jasser S, Wang J . Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers. Clin Cancer Res. 2014; 20(14):3842-8. PMC: 4102633. DOI: 10.1158/1078-0432.CCR-14-0565. View

12.

Parsa A, Waldron J, Panner A, Crane C, Parney I, Barry J . Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med. 2006; 13(1):84-8. DOI: 10.1038/nm1517. View

13.

Chung C, Parker J, Karaca G, Wu J, Funkhouser W, Moore D . Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell. 2004; 5(5):489-500. DOI: 10.1016/s1535-6108(04)00112-6. View

14.

Vokes E, Weichselbaum R, Lippman S, Hong W . Head and neck cancer. N Engl J Med. 1993; 328(3):184-94. DOI: 10.1056/NEJM199301213280306. View

15.

Vokes E, Seiwert T . EGFR-directed treatments in SCCHN. Lancet Oncol. 2013; 14(8):672-3. DOI: 10.1016/S1470-2045(13)70215-8. View

16.

Cohen E . Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol. 2006; 24(17):2659-65. DOI: 10.1200/JCO.2005.05.4577. View

17.

Akagi K, Li J, Broutian T, Padilla-Nash H, Xiao W, Jiang B . Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res. 2013; 24(2):185-99. PMC: 3912410. DOI: 10.1101/gr.164806.113. View

18.

Tabernero J, Bahleda R, Dienstmann R, Infante J, Mita A, Italiano A . Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors. J Clin Oncol. 2015; 33(30):3401-8. DOI: 10.1200/JCO.2014.60.7341. View

19.

Wu Y, Su F, Kalyana-Sundaram S, Khazanov N, Ateeq B, Cao X . Identification of targetable FGFR gene fusions in diverse cancers. Cancer Discov. 2013; 3(6):636-47. PMC: 3694764. DOI: 10.1158/2159-8290.CD-13-0050. View

20.

Pickering C, Zhang J, Yoo S, Bengtsson L, Moorthy S, Neskey D . Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov. 2013; 3(7):770-81. PMC: 3858325. DOI: 10.1158/2159-8290.CD-12-0537. View